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Abstract
Summary We assessed in a cross-sectional study in elderly
men and women with osteoporosis, the association between
the creatinine clearance (CrCl) and the performance in
different balance and muscle power and function tests and
found that a decreasing creatinine clearance was signifi-
cantly associated with lower balance and muscle power.
Introduction To determine if a creatinine clearance of
<65 ml/min is significantly associated with decreasing
muscle power and balance and an increased risk for falls
and fractures.
Methods We assessed in a cross-sectional-study in 1781
German osteoporotic patients, the association between the
CrCl, the physical performance, and the number of falls and
fractures.
Results Controlling for age, gender, BMI, and osteoporosis
treatment (fracture analysis only), a decreasing CrCl was
associated with lower physical performance in the timed-
up-and-go test (corr −0.2337, P<0.0001), chair-rising test
(corr −0.1706, P<0.001), and tandem-stand test (corr
0.2193, P<0.0001), and a CrCl of <65 ml/min was
associated with a significantly higher risk for falls (47.7%
vs. 36.2%, P=0.0008) and fall-related fractures (33.1% vs.
22.9%, P=0.0003) compared with a CrCl of ≥65 ml/min.
Conclusions In this study, we found a significant gender-
independent correlation between decreasing CrCl and lower
performance in balance and muscle power tests. Reduced
muscle power and balance may therefore be involved in the
low creatinine clearance associated increased risk for falls
and fall-related fractures. Furthermore, we found that a
CrCl <65 ml/min., independent from the performance in
muscle power, muscle function, and balance tests, is a
significant risk factor for falls and fractures.
Keywords Balance . Creatinine clearance .
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Introduction
The predisposition of older individuals to falls, which often
results in mobility difficulties and functional decline, is due
to the accumulation of impairments and comorbid con-
ditions with aging, such as muscle weakness, decreased
balance, neuromuscular abnormalities, concomitant arthri-
tis, and chronic diseases [1].
In addition to its vital role in bone formation and
remodeling and maintenance of bone mass, D-hormone
(calcitriol) has been shown to be important for the
maintenance of muscle strength, muscle power, and
function and balance in older individuals [2–4]. Three
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randomized controlled trials [5–7] reported a significant
reduction in the frequency of falls with calcidiol in
institutionalized elderly women with vitamin deficiency
[5] or with either calcitriol [6] or alfacalcidol [7] in
community-dwelling, vitamin D replete elderly women
and men [25(OH) D>30 ng/ml, as defined by the WHO].
In a 4-year observational study, Faulkner et al. described a
significant association between higher calcitriol serum
levels and a reduced risk for falls [8]. These observations
may be explained by the effect of D-hormone on muscle
power and function as well as on balance. Through a highly
selective D-hormone receptor, D-hormone acts directly on
muscle tissue [9] by mediating de novo protein synthesis
and affecting muscle cell growth and differentiation of
muscle fibers,[10, 11].
Recent published studies found a significant associa-
tion between the creatinine clearance, decreasing serum
levels of calcitriol, and an increased risk for falls and
osteoporotic fractures [7, 8, 12–16]. The objective of this
study was to test the hypothesis that a low creatinine
clearance below 65 ml/min, as a surrogate for decreasing
calcitriol serum levels, is associated with lower perfor-
mance in muscle power and balance tests, number of falls
and fallers, and fall-associated fractures in older
community-dwelling independent persons diagnosed with
osteoporosis.
Subjects and methods
This is a cross-sectional German study conducted from
May 2005 till October 2005, with the aim to assess the
association between the creatinine clearance and the
performance in different muscle power and balance tests,
the number of falls and fallers, and fall-associated fractures
in osteoporotic German women and men aged 65 years and
older.
Two hundred eighty-seven medical centers from all over
Germany participated in this study. GP's, specialists in
internal medicine, and orthopedists, who are involved in the
treatment of osteoporotic patients, were asked to fill in a
questionnaire concerning their patients treated for osteopo-
rosis and to perform different muscle power and balance
tests. The questionnaire had to be filled out in the presence
of and with the help of the patient treated for osteoporosis
at a medical visit during the study time period. The three
muscle tests are from the official German guidelines for the
assessment of the patient's risk for falls.
The questionnaire gave information on some demo-
graphic parameters (gender, age, weight, height), the date of
diagnosis of osteoporosis (DD/MM/YY), method of diag-
nosis [dual energy X-ray absorptiometry (DEXA), ultra-
sound, X-rays], duration of osteoporotic treatment (options:
from-till, respectively; long term therapy), and type of
antiosteoporotic treatment (options: bisphosphonates, fluo-
rides, calcitonins, raloxifen, others, no therapy, known
vertebral deformations (yes/no), number of falls within the
last 12 months (intrinsic nonsyncopal/syncopal), number of
osteoporotic fractures within the last 12 months, circum-
stances and numbers of fractures (in association with falls,
no association with falls, numbers), localization of fall-
related fractures, localization of nonfall-related fractures,
and serum creatinine level and creatinine clearance (calcu-
lated). The questionnaire gave no information on how and
with which method the fractures were diagnosed. The
creatinine clearance was calculated using the well-
established formula from Cockcroft-Gault adjusted for gender
[17]. Compared with a direct measurement of the glomerular
filtration rate (GFR) with 24-h urine sampling or inuline
clearance, the Cockcroft-Gault formula gives only an
estimate of the GFR. Nevertheless, the Cockcroft-Gault
formula is widely accepted and used as an easy tool for the
calculation of the creatinine clearance. Participants treated
with alfacalcidol or calcitriol were excluded from the study.
Falls were defined as “unintentionally coming to rest on
the ground, floor, or other lower level”. The study
physicians received training in the use of the fall protocol
(date, time, circumstances, and injuries).
The diagnostic criteria for osteoporosis used by the
physician were not assessed. Therefore, in this study, the
diagnosis of osteoporosis is solely based on the physi-
cians report. Falls were defined as being either intrinsic
nonsyncopal falls or syncopal falls. However, a more
precise classification of the intrinsic nonsyncopal falls
was not performed. Fracture incidence within the last
12 months was assessed as documented in the medical
history of each individual participant and not on patients
recall.
Functional assessment
The association between the creatinine clearance and
functional mobility and balance measured with the timed-
up-and-go (TUG) test, the tandem standing test (TST), and
the chair rising test (CRT) was the main outcome of the
analyses of this cross-sectional study. The study physicians
and their nurses received training in the performance of
these tests.
The TUG test reported by Podsialdo and Richardson is a
measure of functional mobility and tests muscle function,
gait speed, and balance [18]. The TUG test is an effective
method of assessing functional mobility efforts needed in
everyday life [18]. The concept is appealing because it
describes a realistic mobility assessment including potential
fall situations, such as transfer in and out of a chair,
walking, and turning [19]. The person is observed and
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timed while arising from an arm chair (seat height 48 cm;
arm height 68 cm), walking 3 m at a normal speed, and
going around an obstacle on the floor (i.e., a brick at 3-m
distance from the chair), returning, and sitting down again.
Subjects are allowed to use the arms of the chair to get up.
Only one trial has to be performed. The longer a patient
needs to perform the TUG the lower his performance.
Recently, it has been shown in a 10-year longitudinal study
that the TUG is not only a measurement of functional
mobility but that it can also be used as a predictor for
nonvertebral fractures: a 1-SD (2.6 s) increase in TUG
performance was, in this study, associated with a 24%
increase in the risk for nonvertebral fractures [20].
The TST, as described by Guralnik et al. and Gill et al.
[21, 22], tests balance capacity. The individual is asked to
stand in a position with feet held tight and close for 10 s,
then to stand at a semitandem for 10 s, and then at a full
tandem where both feet are directly in line, the heel of the
leading foot directly in front of the toes of the other. A
maximum of three attempts is allowed from which the best
performance is being counted. Inability to stand in this
position for at least 10 s indicates a high risk for falls. The
longer a patient can hold his position in the TST the better
his performance.
In the chair rising test, for testing muscle power [19,
21, 23], an individual is asked to stand up and sit down
five times from a chair of usual height as quickly as
possible without using the arms. The arms are crossed in
front of the chest. Only one trial has to be performed. An
individual who is not able to sit and rise five times or
performs the test in more than 10 s is at high risk to fall.
The longer a patient needs to perform the CRT the lower
his performance.
Statistical analysis
For the main analyses, we used Spearman's correlation
analyses, logistic regression analyses, and pooled linear
regression models to control simultaneously for several
potentially confounding variables. Comparisons of means
were performed by multivariate adjusted analyses of
variance [24]. Since age and body mass index (BMI)
distributions were markedly skewed, logarithmic transfor-
mation of these variables were performed prior to analyses.
Since TUG was not normally distributed, we used log
transformed TUG. We included covariates used in the
models which we suggested or were suggested in previous
studies [25, 26] to be associated with functional perfor-
mance. These covariates were gender (male, female), which
was analyzed as a dichotomous variable; age; BMI; and
creatinine clearance, which were analyzed as continuous
variables. For all other analyses, we used t test, Wilcoxon
rank-sum test, and Chi-square test.
For all analyses, we used SAS version 9.1 by the SAS
Institute Inc., Cary, NC, USA, licensed to the University of
Basel, Switzerland.
Data, Safety, and Monitoring Board, established by
GWD Consult Germany (Safety and Monitoring Board:
GWD Consult, Research Contract, Postfach 1210, 63152
Mülheim/Main, Germany), reviewed the conduct of the
study.
Results
Demographics (Table 1)
One thousand four hundred ten (79.2%) women and 371
(20.8%) men participated in this study (Table 1). The mean
age of the study participants was 74.2 years, and partic-
ipants were slightly overweight with a mean body mass
index of 26.1 kg/m2.
Women in this study group were slightly older than men
[mean age, 74.6 years (age range, 61–99 years) vs. mean
age 72.9 years (age range, 61–90 years)]. Concerning the
performance in the muscle and balance tests, women were
significantly slower than men in the chair rising test (mean
performance time, 13.5 vs. 12.1 s, p=0.05), whereas for the
TUG and the TST, there was no statistical significance
difference between genders (Table 1).
Creatinine clearance, osteoporosis, osteoporotic treatment,
and falls
Participants in this study had a mean creatinine clearance of
60.2 ml/min 1,130 (63.5%) participants had a CrCl of
<65 ml/min. Women were significantly more prone to have
a low creatinine clearance than men (68.65% vs. 43.67%,
p<0.0001).
In the 1,410 participants, osteoporosis was diagnosed in
19.9% of the participants within the study year, and for the
majority of the 1,410 participants (63.75%), osteoporosis
was known for not more than 5 years. Only a minority of
16.35% had a long-time diagnosis of osteoporosis of more
than 5 years. Osteoporosis was diagnosed in 42.7% by
DEXA only, in 17.4% with DEXA and X-ray (total DEXA
60.1%), in 4.4% with ultrasound of the calcaneus, and in
34.5% with X-ray only. At the time of the study, 36.4% of
the 1,410 participants received a treatment with bisphosph-
onates, 4.6% with fluorides, 3.8% with calcitonin, 2.2%
with raloxifen, and 3.8% received other not specified
therapy for osteoporosis. Of the 1,410 participants, 54.2%
received no specific therapy for osteoporosis, and for 9.4%
of the 1410 participants, there was no information on
treatment. Of all 1,410 patients, 61.2% were under a
treatment with vitamin D and calcium.
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Of the participants, 70.4% presented vertebral deforma-
tions, which were significantly present in more participants
with a creatinine clearance of <65 ml/min than in
participants with a creatinine clearance of ≥65 ml/min
(73.4% vs. 64.3%, p<.0001).
Within the last 12 months before the study visit, a total
of 907 falls were registered. From the participants who
reported a fall, 43.1% reported a single fall and 56.9%,
multiple falls. Participants with a creatinine clearance of
less than 65 ml/min reported significantly more non-
syncopal falls and were prone to experience multiple falls
than participants with a creatinine clearance of ≥65 ml/min
(47.7% vs. 36.2%, p = 0.0008, multivariate controlled and
28.0% vs. 18.4%, p<0.001, multivariate controlled, respec-
tively). For syncopal falls, we found no significant
difference between groups according to the creatinine
clearance (<65 ml/min vs. >65 ml/min; 9.7% vs. 13.8%,
p=0.13). Treatment of osteoporosis did not affect falls.
Performance in the different muscle power and balance
tests, the creatinine clearance, and the association to fall
incidence (Table 1 and Fig. 1)
A CrCl of ≤65 ml/min was controlled for age, gender, and
BMI, compared with a CrCl of ≥65 ml/min, and associated
with a significantly higher incidence for falls (OR, 1.40;
95% CI 1.12–1.74, p=0.002) and a significantly higher risk
for multiple falls (OR, 1.42; 95% CI 1.09–1.85, p=0.010).
A decreasing CrCl was controlled for age, gender, and BMI
significantly associated with lower performance in the TUG
test (corr −0.2337, p<0.0001), in the chair rising test (corr
−0.1706, p<0.0001), and the tandem stand (corr 0.2193,
p<0.0001). These findings were significant in both gen-
ders. However, the correlation coefficient for all tests was
higher in men.
Accrodingly, to this finding, participants with a creati-
nine clearance of <65 ml/min had controlled for age,
gender, and BMI, significant lower performance in the
TUG (13.0 vs. 11.1 s, p=0.005), the TST (9.5 vs. 10.6 s,
p<0.001), and CRT (14.0 vs. 11.7 s, p=0.003) compared
with participants with a creatinine clearance of ≥65 ml/min.
The timed-up-and-go test as well as the TST were
significantly associated with the number of falls (point
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Fig. 1 Physical performance in different muscle power and balance
tests, TUG (open diamond), TST (open square), and CRT (open
triangle), according to the creatinine clearance
Table 1 Characteristics of subjects and physical performance in muscle and balance tests according to gender and according to a creatinine
clearance of <65 ml/min vs. ≥65 ml/min
Gender p Value Gender p Valuea*
Men Women Men Women
CrCl (ml/min) <65 ≥65 <65 ≥65
Age (years) 74.6 72.9 ≤0.0001 75.2 71.2 76.0 71.4 <0.001
BMI (kg/m²) 26.4 26.0 0.074 25.6 27.0 25.1 27.9 <0.001
TUG (s) 12.4 11.8 0.11° 13.1 10.7 12.9 11.3 0.042a
TST (s) 9.9 10.0 0.85° 9.1 10.6 9.6 10.6 0.004a
CRT (s) 13.5 12.1 0.005° 13.1 11.0 14.1 12.0 0.012a
Fallsb (%) 43.1 43.8 0.26a 47.5 39.7 47.7 35.1 0.01
Fall-associated fractures (%) 35.9 36.0 0.66a 45.1 28.7 40.1 26.9 <0.001
CrCl creatinine clearance in milliliters per minute, BMI body mass index in weight (kilograms) per height (squaremeter), TUG timed-up-and-go
test, TST tandem stand test, CRT chair rising test
a Controlled for age, BMI, and the use of vitamin D and calcium (and for the fracture analyses, type of osteoporosis treatment)
b Falls during study time in percent of the population
* p Value for the difference between CrCl <65 ml/min vs. ≥65 ml/min
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estimate, −0.05, p<0.0007; res., 0.06, p<0.0001) and the
number of frequent fallers (point estimate, −0.05, p<0.0002;
res., 0.07, p<0.0001), whereas the CRT was not associated
to the incidence of falls (p=0.43) but to the number of
frequent fallers (point estimate, 0.028, p=0.02). Multivar-
iate controlled, including for the performances in the TUG,
TST, and CRT a low CrCl of <65 ml/min, still remained a
significant predictor for falls (OR, 1.35, 95%CI 1.06–1.73,
p=0.016) and for the number of frequent fallers (OR, 1.40,
95% CI 1.04–1.87, p=0.023).
Fall-associated fractures and creatinine clearance (Fig. 2)
Of the participants, 36% experienced a fall-related fracture
within the last 12 months (N=641) including 6.7% who
experienced more than one fall-related fracture. Patients
with a creatinine clearance of <65 ml/min experienced
significantly 44% more fall-related fractures than partic-
ipants with a creatinine clearance of ≥65 ml/min (33.1% vs.
22.9%, p=0003, multivariate controlled). In 95%, the
localization of the fracture was specified—39.5%vertebral
fractures, 20.4% hip fractures, 26.3% fractures of the
radius, and 13.8% other localization (mostly of the feet
and shoulder/humerus). Participants with a creatinine
clearance of <65 ml/min had controlled for age, gender,
BMI, and osteoporosis treatment, significantly more verte-
bral fractures (OR, 1.50, 95% CI 1.04–2.15, p=0.03), hip
fractures (OR, 1.82, 95% CI 1.14–2.91, p=0.012), and
fractures of the radius (OR, 1.73, 95% CI 1.15–2.60,
p=0.012) but not significantly more fractures of other
localization (OR, 1.54, 95% CI 0.68–3.51, p=0.205) than
participants with a creatinine clearance of ≥65 ml/min.
The incidence of fall-associated fractures was signifi-
cantly associated to the creatinine clearance (p<0.0001).
We observed a stepwise increase of fall-associated frac-
tures: participants with a creatinine clearance of ≥70 ml/min
had a mean risk of 28.9% to experience a fall-associated
fracture. With a creatinine clearance between <70 ml/min
and ≥40 ml/min, participants had a mean 45.3% to
experience a fall-associated fracture or a significant 1.56
increased risk compared with participants with a creatinine
of ≥70 ml/min (p<0.001). Below 40 ml/min, this risk
increased to a mean risk of 71.6% to experience a fracture
while falling or a 2.47 increased risk compared with
participants with a creatinine of ≥70 ml/min (p<0.0001).
A total of 137 nonfall-associated fractures were regis-
tered, mostly vertebral fractures (N=113, 82.5%). We found
no significant statistical difference for nonfall-associated
fractures according to the creatinine clearance (<65 ml/min
vs. ≥65 ml/min, 7.9% vs. 6.9%, p=0.46).
Discussion
In this study, we observed that osteoporotic elderly men and
women with a low creatinine clearance of <65 ml/min
showed significantly poorer performance in muscle and
balance tests, experienced significantly more falls and
fractures, and were significantly more prone to be frequent
fallers than osteoporotic elderly men and women with a
creatinine clearance of ≥65 ml/min. A low creatinine
clearance of <65 ml/min, as a surrogate marker for
decreasing calcitriol serum levels, was independent from
the performance in muscle power and balance tests
significantly associated with a higher incidence of falls
and fractures.
A reduction in demands for health care resources in
older individuals can be achieved by maintaining functional
capacity and mobility in order to keep older persons
independent [27–29]. Ways of improving and maintaining
function with aging is an important research and public
health agenda. There is improving evidence that alfacalci-
dol and calcitriol, besides their well-known effects on bone
metabolism [30, 31], enhance muscle power [32, 33] and
reduce falls and fall-associated fractures in older persons [6,
7, 14, 15]. Muscle weakness affects balance and functional
mobility, which puts an older person at increased risk of
falling and fractures [34]. The association between calci-
diol, D-hormone, and muscle strength has been investigated
in preclinical studies, observational studies, and random-
ized controlled trials, and the majority of these studies are
consistent with the proposition that activated vitamin D is
important, if not essential, for normal muscle strength [11].
In previous reports, it was shown that ambulatory older
men and women with higher D-hormone serum concen-
trations had better leg extension power [2] and better
muscle function [4] compared with older persons with low
D-hormone serum concentrations. Stein and colleagues
observed low calcidiol and high parathormone (PTH)
serum concentrations in elderly fallers [35]. Faulkner et
al. showed that only higher D-hormone concentrations are
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Fig. 2 Fracture rate per 100 falls according to the creatinine clearance
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significantly associated with a lower risk of falls in older
community-dwelling women, whereas vitamin D supple-
mentation and calcidiol and PTH concentrations were not
associated with either neuromuscular function or falls [8].
Aging is associated with impaired renal function [36,
37] easily measurable as deterioration of the creatinine
clearance, which leads to decreased activity of the renal 1α-
hydroxylase [38–40] and, consecutively, to low D-hormone
serum levels [41–43]. Muscle strength, balance, and
functional mobility depend on D-hormone serum levels [2,
4, 6, 10, 37, 44–47]. In a recently published case-control
study including almost 700 women aged 65 years or older,
Ensrud et al. showed that the risk of new hip fracture
increases 2.3 times in women with moderate impairment of
renal function (CrCl of <45 ml/min) and 1.6 times in
women with a CrCl of 45 to 59 ml/min compared with
women with a CrCl >60 ml/min [16]. The risk for
trochanteric hip fracture was even higher and increased
7.2-fold in women with a CrCl of <45 ml/min and 3.9-fold
in those with a CrCl of 45 to 59 ml/min compared with
women with a CrCl of >60 ml/min [16]. However, the risk
of vertebral fractures was not significantly associated with
renal function [16]. These results are in line with a cross-
sectional and a prospective longitudinal study including
1,713 healthy community-dwelling men and women with
an average age of 71 years [37]. The Rancho Bernardo
study found a significant linear association between renal
function and hip bone mineral density. In addition, a
significant association has been shown between renal
function and tandem gait and speed of gait [37]. It was
shown in several studies [6, 7] that a treatment with D-
hormone (alfacalcidol and calcitriol, respectively) signifi-
cantly reduced the risk of falls and of fall-associated
fractures. One study showed that treatment with alfacalcidol
in community-dwelling elderly men and women with a low
CrCl of <65 ml/min significantly decreases the low CrCl-
associated high risk for falls [13]. In another placebo
controlled study with 489 women aged 65–77 years,
Gallagher et al. confirmed recently that a low CrCl of
<60 ml/min is a statistically significant predictor of falls
[15], and in his study, he found a similar risk for falls and
fall-related fractures as we reported in this study [15]. A
similar risk for falls and fall-related injuries was also
described in the study by Gryfe et al. [48]. In the low CrCl
group (<60 ml/min) in the Gallagher et al. study [15], the
rate of falls decreased with a 3-year D-hormone treatment
by 53% (p=0.003) and by 30% in the group with a CrCl of
>60 ml/min. In the placebo group, women with a CrCl
<60 ml/min had at baseline 60% higher rate of history of
falls compared with the group with CrCl ≥60 ml/min (p=
0.007). Compared with women with a CrCl of ≥60 ml/min,
women with a CrCl of <60 ml/min had, in addition, lower
calcium absorption (p<0.001), lower serum D-hormone (p<
0.001), lower physical performance, and normal serum 25
(OH)D (p<0.05) suggesting that there is a decreased
conversion of 25(OH)D to 1,25(OH)2D (D-hormone) when
the CrCl decreases below 60 ml/min. Besides the lower
kidney mass in the elderly, increased CRP, higher cytokine
serum levels, and/or elevated concentrations of fibroblast
growth factor 23, which is produced to maintain normal
phosphatemia, inhibit renal 1α-hydroxylase activity, and
some of these factors may also have a direct detrimental
effect on bone quality and muscle power [40, 49, 50]. In
summary, a low creatinine clearance is associated with an
increased risk for osteopenia and osteoporosis [14, 15, 27,
37, 51], lower physical performance, increased falls and hip
fractures, and possibly, increased frailty. Our results and the
results from other studies [2, 4, 6, 11, 15, 16, 20, 34–36, 38,
50, 52] allow us to theorize that calcitriol is directly
involved in the causal pathogenic pathway of decreased
muscle strength, decreased balance and related falls and
fractures, and that a decreasing calcitriol serum level and/or
a low concentration at the target organs is a risk factor for
falls and fall-related fractures. However, in this study, we
showed, indirectly (using a creatinine clearance of <65 ml/
min as a surrogate for decreasing calcitriol serum levels),
that, independent from muscle strength and balance
performance, a decreasing calcitriol serum level is a risk
factor for falls and fall-related fractures. Therefore, we
conclude that, calcitriol, besides its influence on muscle and
bone, may have other effects, i.e., on neuromuscular
transmission and cognition. Few studies exist on this
subject. The brain has calcitriol receptors [53], and it has
been shown that calcidiol as well as calcitriol [54] serum
levels are significantly correlated to cognitive function and
the performance in different cognitive test and depression in
older adults, respectively [55]. In animal studies, it was
shown that Vitamin D Receptor (VDR) receptor knockout
mice have muscular and motor impairments that signifi-
cantly affect locomotor behavior [11, 56].
It is postulated that an increase in D-hormone in serum and/
or at the target organs would up-regulate VDR in muscles
although one cannot exclude an up-regulation of VDR in
brain and an effect on the central nervous system [15, 57].
Interestingly, instead of a continuous increase of the risk
of fall-associated fractures, we observed in this study a
stepwise increase, namely, a 56% increased risk with a CrCl
between 40 and 70 ml/min and a 147% increased risk with
a CrCl of <40 ml/min compared with a CrCl of ≥70 ml/min.
As described previously, we and others observed a
significant decline of D-hormone serum levels with a CrCl
of <65 ml/min. A CrCl-dependent increase of intact
parathormone (iPTH) serum levels was described by
different authors [38, 58, 59] when the CrCl decreases
below 40 ml/min. We therefore raise the hypothesis that the
risk of fall-associated fractures increases in two steps: first,
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when it comes to a critical CrCl-associated cut point of
decreasing D-hormone serum levels and a second increase
in the risk of fall-associated fractures, when it comes to a
critical CrCl-associated increase in iPTH serum levels.
Further studies are needed to confirm our findings. If
confirmed, this would open new and tremendous possibili-
ties of a much more differentiated approach of the treatment
of fall-associated fractures.
Our study has several limitations. The results are from a
cross-sectional study with its well-known limitations of
interpretation. The outcome variable “falls” was assessed
by recall with the inherent recall bias. Concerning the fall-
associated fractures, we also did not assess how the
fractures were diagnosed or confirmed, and we did not
assess history of fractures, which would have been an
important control variable for this outcome variable. In
general, we also could not control for other important
covariates such as comorbid conditions, number of medi-
cations, physical activity, and other not-assessed control
variables. Therefore, we cannot rule out uncontrolled
confounding. Furthermore, the diagnosis of osteoporosis
was solely based on different radiological methods. We can
therefore not rule out a miss-classification concerning the
diagnosis of osteoporosis. We can assume that this possible
miss-classification concerns the whole study group and
does not influence our result on the influence of a low
creatinine clearance on the muscle power and balance
performance as well as on frequency of falls and fractures
in this population. The participants were Caucasian elderly
men and women over the age of 65 years treated for
osteoporosis. The diagnosis of osteoporosis was not for all
participants based on BMD. Therefore, our findings are not
generalizable to a general osteoporotic population, to a
younger population, or to osteoporotic men and women of
other races.
In summary, we found that muscle power and balance
performance, as assessed by the TUG, TST, and CRT tests,
are significantly related to the creatinine clearance. A
creatinine clearance of <65 ml/min is associated with
poorer performance in all muscle and balance tests.
Surprisingly, a low CrCl of <65 ml/min was independent
from the performance in muscle power and balance tests
significantly associated with a higher incidence of falls and
fall-related fractures. Since a low creatinine clearance of
<65 ml/min can be considered as a surrogate marker for
low calcitriol serum levels, we conclude therefore that
preventive health and rehabilitation strategies should aim to
correct D-hormone deficiency in elderly men and women
with a creatinine clearance of <65 ml/min in order to
maintain muscle power and balance and to prevent falls and
fall-associated fractures.
Low CrCl seemed to be a prognostic tool for low hip
BMD, low bone strength, decreased muscle performance,
increased risk of falls and fall-related fractures, and
possibly, of frailty. A very useful diagnosis of the frailty
syndrome defined by decreased bone strength, decreased
mobility, decreased cognitive capabilities, and increased
risk of falls and fractures, especially hip fractures, may be a
simple calculation of CrCl from serum creatinine based on
the Cockcroft-Gault formula. This attractive hypothesis
must be confirmed in further clinical studies because it
would be of great economic relevance to delay the frailty
before it transfers to disability.
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